AbCyte Therapeutics

AbCyte Therapeutics Inc. was founded in January 2016 by Dr. Yongke Zhang, an American of Chinese origin. The company is mainly engaged in the research and development of a new generation of precision tumor-specific T cell individual treatment platform, as well as related innovative and multifunctional antibodies for antibody and cell therapy for cancer and other serious diseases.